60. 再生不良性貧血 Aplastic anemia Clinical trials / Disease details

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

19 trials found

diseases per page:

Showing 1 to 10 of 19 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05323617 (ClinicalTrials.gov)	May 15, 2023	5/4/2022	Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Imm ...	Two Arm Bridging Study to Evaluate the Efficacy of Romiplostim in the Treatment of Adult Severe Apla ...	Severe Aplastic Anemia (SAA)	Drug: Romiplostim;Drug: Antithymocyte Globulin;Drug: Cyclosporine A	Amgen	NULL	Not yet recruiting	18 Years	N/A	All	40	Phase 2	NULL
2	NCT05049668 (ClinicalTrials.gov)	October 2021	13/9/2021	RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial	Long-term Follow-up of Patients Participating in RACE: the Prospective Randomized Multicenter Study ...	Severe Aplastic Anemia	Drug: ATGAM plus CsA with or without Eltrombopag	European Society for Blood and Marrow Transplantation	NULL	Enrolling by invitation	N/A	N/A	All	197		France
3	NCT04328727 (ClinicalTrials.gov)	November 4, 2020	9/3/2020	Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplasti ...	A Non-randomized, Open Label, Multi-center, Phase II Study to Assess the Safety and Efficacy of Eltr ...	Severe Aplastic Anemia (SAA)	Drug: eltrombopag;Drug: rabbit anti-thymocyte globulin (r-ATG);Drug: cyclosporine A (CsA)	Novartis Pharmaceuticals	NULL	Active, not recruiting	6 Years	N/A	All	36	Phase 2	China;Japan;Korea, Republic of;Taiwan
4	NCT04304820 (ClinicalTrials.gov)	May 7, 2020	10/3/2020	Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplast ...	Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplast ...	Severe Aplastic Anemia	Drug: Eltrombopag;Drug: Cyclosporine;Drug: Horse-Anti-thymocyte-Globulin	National Heart, Lung, and Blood Institute (NHLBI)	NULL	Recruiting	3 Years	N/A	All	39	Phase 2	United States
5	EUCTR2016-002814-29-IT (EUCTR)	14/06/2019	24/05/2021	SOAR, Interventional phase II single-arm study to assess efficacy and safety of eltrombopag combined ...	SOAR, Interventional phase II single-arm study to assess efficacy and safety of eltrombopag combined ...	First-line severe aplastic anaemia MedDRA version: 20.0;Level: PT;Classification code 10002967;Term: ...	Trade Name: SANDIMMUN NEORAL- 10 MG CAPSULE MOLLI 50 CAPSULE Product Name: Sandimmun Neoral Product Co ...	NOVARTIS PHARMA AG	NULL	Not Recruiting			Female: yes Male: yes	50	Phase 2	Hungary;Hong Kong;Mexico;Spain;Thailand;Brazil;Korea, Democratic People's Republic of;Turkey;Netherl ...
6	JPRN-UMIN000030453	2017/12/20	18/12/2017	Efficacy of cyclosporine therapy in the treatment of non-severe aplastic anemia	Efficacy of cyclosporine therapy in the treatment of non-severe aplastic anemia - Aplastic anemia 01 ...	aplastic anemia	1.Start CsA(Neoral or generic drugs emulsified in the same way as Neoral) at a dose of 3.5 mg/kg, bi ...	Cooperative study between the West Japan Hematology Study Group and Clinical Research Support Center ...	NULL	Complete: follow-up continuing	16years-old	Not applicable	Male and Female	33	Not selected	Japan
7	EUCTR2016-002814-29-HU (EUCTR)	07/09/2017	05/07/2017	SOAR Trial: Eltrombopag combined with cyclosporine as first line therapy in patients with severe acq ...	SOAR Trial, A two-part study: Interventional phase II single-arm trial to assess efficacy and safety ...	First-line severe aplastic anaemia MedDRA version: 20.0;Level: PT;Classification code 10002967;Term: ...	Trade Name: REVOLADE Product Name: Eltrombopag Product Code: ETB115 INN or Proposed INN: ELTROMBOPAG	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	50	Phase 2	France;Hong Kong;Hungary;Mexico;Spain;Brazil;Turkey;Netherlands;Italy;Korea, Republic of;India
8	EUCTR2016-002814-29-NL (EUCTR)	21/07/2017	29/03/2017	SOAR Trial: Eltrombopag combined with cyclosporine as first line therapy in adult patients with seve ...	SOAR, Interventional phase II single-arm study to assess efficacy and safety of eltrombopag combined ...	First-line severe aplastic anaemia MedDRA version: 20.0;Level: PT;Classification code 10002967;Term: ...	Trade Name: REVOLADE Product Name: Eltrombopag Product Code: ETB115 INN or Proposed INN: ELTROMBOPAG	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	50	Phase 2	Hungary;Hong Kong;Mexico;Thailand;Spain;Brazil;Turkey;Netherlands;Italy;Korea, Republic of;India
9	EUCTR2016-002814-29-ES (EUCTR)	21/03/2017	16/12/2016	SOAR Trial: Eltrombopag combined with cyclosporine as first line therapy in patients with severe acq ...	SOAR Trial, A two-part study: Interventional phase II single-arm trial to assess efficacy and safety ...	First-line severe aplastic anaemia MedDRA version: 19.0;Level: PT;Classification code 10002967;Term: ...	Trade Name: REVOLADE Product Name: Eltrombopag Product Code: ETB115 INN or Proposed INN: ELTROMBOPAG Tra ...	Novartis Farmacéutica, S.A	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	50	Phase 2	Qatar;Hong Kong;Spain;Turkey;Italy;India;France;Hungary;Mexico;Canada;Brazil;Netherlands;Korea, Repu ...
10	NCT03413306 (ClinicalTrials.gov)	December 10, 2016	22/12/2017	Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA	A Phase II Multicenter Randomized Study of Eltrombopag Combined With Cyclosporine and hATG Versus hA ...	Acquired Aplastic Anemia	Drug: Eltrombopag;Drug: IST (ATG + CsA)	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	NULL	Recruiting	2 Years	18 Years	All	100	Phase 3	Russian Federation

First Previous1 2Next Last